CovidVax show full list
COVID-19 VACCINE:

RBD tetanus + Adjuvant (FINLAY-FR2)

researcher:
Instituto Finlay de Vacunas
https://www.finlay.edu.cu/
(Cuba)
vaccine type: Protein subunit
Distribution updates
currently no distribution info
Human Testing updates (clinical trials)

PHASE 1

 

started November 2 2020

with 40 healthy volunteers aged 19-59

trial location: Cuba

» clinical trial details

PHASE 2

 

started December 21 2020

with 910 healthy volunteers aged 19-80

trial location: Cuba

» clinical trial details

PHASE 3

 

started March 5 2021

with 44010 healthy volunteers aged 19-80

trial location: Cuba

» clinical trial details

Mar 08Soberana 02 started Phase 3 clinical trials Monday in the capital Havana with a population segment between 19 to 64 years of age (by cubanews.acn.cu)
Feb 07Cuban's vaccine Soberana 02 will start its Phase 3 trial in March by enrolling 42600 participants (by jornada.com.mx)
Nov 02FinlayInstituto's second vaccine Soberana 2 Phase 1 clinical trials is beginning on Nov. 2 (by plenglish.com)
Animal Testing updates (pre-clinical trials)
currently no pre-clinical trials info
early development updates
currently no early development info






contact | about | ©2020 CovidVax.org project